Show simple item record

dc.contributor.authorHuergo Baños, Cristina
dc.contributor.authorVelasco, Verónica
dc.contributor.authorGarate Yeregui, Jone
dc.contributor.authorFernández Regueira, Roberto Antonio ORCID
dc.contributor.authorMartín Allende, Javier
dc.contributor.authorZabalza Estévez, Ignacio
dc.contributor.authorArtola Igarza, Juan Luis
dc.contributor.authorMartí Laborda, Rosa María
dc.contributor.authorAsumendi Mallea, Aintzane ORCID
dc.contributor.authorAstigarraga, Egoitz
dc.contributor.authorBarreda Gómez, Gabriel
dc.contributor.authorFresnedo Aranguren, María Olatz
dc.contributor.authorOchoa Olascoaga, Begoña
dc.contributor.authorBoyano López, María Dolores ORCID
dc.contributor.authorFernández González, José Andrés ORCID
dc.date.accessioned2024-05-02T18:03:11Z
dc.date.available2024-05-02T18:03:11Z
dc.date.issued2024-02
dc.identifier.citationInternational Journal of Cancer 154(4) : 712-722 (2024)es_ES
dc.identifier.issn1097-0215
dc.identifier.issn0020-7136
dc.identifier.urihttp://hdl.handle.net/10810/67337
dc.description.abstractProbably, the most important factor for the survival of a melanoma patient is early detection and precise diagnosis. Although in most cases these tasks are readily carried out by pathologists and dermatologists, there are still difficult cases in which no consensus among experts is achieved. To deal with such cases, new methodologies are required. Following this motivation, we explore here the use of lipid imaging mass spectrometry as a complementary tool for the aid in the diagnosis. Thus, 53 samples (15 nevus, 24 primary melanomas, and 14 metastasis) were explored with the aid of a mass spectrometer, using negative polarity. The rich lipid fingerprint obtained from the samples allowed us to set up an artificial intelligence-based classification model that achieved 100% of specificity and precision both in training and validation data sets. A deeper analysis of the image data shows that the technique reports important information on the tumor microenvironment that may give invaluable insights in the prognosis of the lesion, with the correct interpretation.es_ES
dc.description.sponsorshipThis project was supported by grants from the Basque Government (KK2017-041 and KK2020-00069 to JAF, BO and MDB and grant IT1491-22 to JAF), the UPV/EHU (GIU17/066 to MDB) and by MINECO (RTC-2015-3693-1).es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/RTC-2015-3693-1es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectbiomarkerses_ES
dc.subjectlipid imaging mass spectrometryes_ES
dc.subjectmelanomaes_ES
dc.subjectmolecular histologyes_ES
dc.titleLipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma sampleses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/full/10.1002/ijc.34800es_ES
dc.identifier.doi10.1002/ijc.34800
dc.departamentoesBiología celular e histologíaes_ES
dc.departamentoesFisiologíaes_ES
dc.departamentoesLenguajes y sistemas informáticoses_ES
dc.departamentoesQuímica físicaes_ES
dc.departamentoeuFisiologiaes_ES
dc.departamentoeuHizkuntza eta sistema informatikoakes_ES
dc.departamentoeuKimika fisikoaes_ES
dc.departamentoeuZelulen biologia eta histologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Except where otherwise noted, this item's license is described as © 2023 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.